Insulin glargine and cancer: another side to the story?

Lancet. 2009 Aug 15;374(9689):521. doi: 10.1016/S0140-6736(09)61477-X.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Evidence-Based Practice
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Mitogens / adverse effects
  • Neoplasms* / chemically induced
  • Neoplasms* / epidemiology
  • Peer Review, Research
  • Research Design
  • Risk Factors

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Mitogens
  • Insulin Glargine